Director Harjit Gill filed a Form 4 with the SEC on November 20, 2026, disclosing the acquisition of 1,109 restricted stock units of ResMed Inc on November 19, 2026, at no cost.
Key Highlights
- Award date: Harjit Gill received 1,109 shares of ResMed Common Stock in the form of Restricted Stock Units on November 19, 2026.
- Price paid: The RSUs were acquired at a price of $0, according to the filing.
- Vesting schedule: The RSUs vest in full on the earlier of November 11, 2027, or the annual meeting of stockholders in the year following the grant date.
- Post-transaction ownership: Following the award, Gill beneficially owns 12,013 shares of ResMed Common Stock directly.
- Reporting person role: Harjit Gill is identified in the filing as a Director of ResMed Inc.
ResMed Director Harjit Gill's November 2026 RSU Award Details
According to the Form 4 filed on November 20, 2026, Harjit Gill, a director of ResMed Inc (NYSE:RMD), reported the acquisition of 1,109 shares of ResMed Common Stock in the form of Restricted Stock Units. The transaction date was November 19, 2026, and the RSUs were acquired at a price of $0, consistent with a standard equity award grant rather than an open-market purchase.
The filing's explanation of responses states that the RSUs "vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date." No derivative securities were reported in Table II of the filing. The award was reported as a direct holding, with no indirect beneficial ownership noted.
Following the reported transaction, Gill's total direct beneficial ownership of ResMed Common Stock stands at 12,013 shares, as disclosed in the filing. The Form 4 was filed by one reporting person and is not an amendment to a prior filing. The filing was signed by Harjit Gill in the capacity of Director on November 20, 2026.
What Was Disclosed
ResMed director Harjit Gill disclosed the receipt of 1,109 Restricted Stock Units of ResMed Common Stock on November 19, 2026, at no cost, with vesting no later than November 11, 2027, bringing direct beneficial ownership to 12,013 shares.



Please wait processing your request...